29(top 2%)
papers
1.4K(top 2%)
citations
19(top 2%)
h-index
27(top 2%)
g-index
29
all documents
1.5K
doc citations
552
citing journals

Top Articles

#TitleJournalYearCitations
1Genome-wide association study identifies multiple susceptibility loci for pancreatic cancerNature Genetics2014294
2VATS Lobectomy Has Better Perioperative Outcomes Than Open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance)Annals of Thoracic Surgery2015170
3Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation RatesAnnals of Surgery2015154
4CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon CancerGastroenterology2014118
5A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)Annals of Oncology201772
6Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)PLoS ONE201465
7Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503Journal of Thoracic and Cardiovascular Surgery201764
8Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)Breast Cancer Research and Treatment201663
9Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)Cancer Epidemiology Biomarkers and Prevention201852
10CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK CellsCancer Immunology Research201448
11Clinical impact ofABL1kinase domain mutations andIKZF1deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665Leukemia and Lymphoma201645
12Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)Annals of Oncology201743
13Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)Leukemia and Lymphoma201536
14Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)Pharmacogenomics Journal201433
15Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/AllianceClinical Colorectal Cancer201331
16The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance)Leukemia and Lymphoma201327
17Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)Cancer Chemotherapy and Pharmacology201427
18A randomized trial of diet in men with early stage prostate cancer on active surveillance: Rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance])Contemporary Clinical Trials201427
19Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated lociPharmacogenetics and Genomics201826
20A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)Investigational New Drugs201321
21The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance)Journal of Geriatric Oncology201814
22A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502Blood201214
23Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II studyBritish Journal of Haematology201510
24Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative)Journal of the American College of Surgeons20178
25Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)British Journal of Clinical Pharmacology20147
26Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)Blood20132
27FINAL RESULTS OF CALGB 50803 (ALLIANCE): A PHASE 2 TRIAL OF LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMAHematological Oncology20171
28Obesity Is An Adverse Prognostic Factor For Overall and Disease-Free Survival In Adult Acute Promyelocytic Leukemia But Not In Acute Myeloid Leukemia: A Pooled Analysis From Four Alliance Prospective StudiesBlood20131
29Abstract 3388: Genetic prediction of VEGF-A plasma levels in cancer patients20160